Ts. Lin et Hy. Fang, Transthoracic endoscopic sympathectomy for craniofacial hyperhidrosis: Analysis of 46 cases, J LAP ADV A, 10(5), 2000, pp. 243-247
Citations number
16
Categorie Soggetti
Surgery
Journal title
JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES-PART A
Background and Purpose: Craniofacial hyperhidrosis may result in social pho
bia and has a strong negative impact on the quality of life. The traditiona
l therapeutic options are psychotherapy and pharmacologic treatment, but th
ese often fail. We wished to investigate whether transthoracic endoscopic s
ympathectomy (TES) of the lower part of the stellate ganglion is efficient
and safe in the treatment of craniofacial hyperhidrosis.
Patients and Methods: Between July 1995 and September 1999, a total of 21 m
en and 25 women with a mean age of 41.2 years (range 22-58 years) underwent
TES for craniofacial hyperhidrosis. All patients were placed in a semisitt
ing position under single-lumen intubated anesthesia. We ablated the lower
part of the stellate ganglion at the second rib using a storz 8-mm 0 degree
s thoracoscope via one 0.8-cm incision just below each axilla, Questionnair
es were sent to all patients postoperatively,
Results: Among these 46 patients, 92 sympathectomies were performed, Usuall
y, TES was accomplished within 15 minutes (range 7-20 minutes), The surgica
l complications were minimal: one segmental atelectasis of the lung (2%), T
here was no surgical mortality, With a mean postoperative follow-up of 32.1
months (range 3-51 months), the results of TES were highly satisfactory in
most patients although 37 (80%) developed compensatory sweating of the tru
nk and lower limbs, the distribution being the axillae in 15 (33%), back in
36 (78%), lower chest and abdomen in 22 (48%), lower limbs in 34 (74%) and
sole in 1, The recurrence rates of craniofacial hyperhidrosis were 0 in th
e first and the second years and 2% each in the third and fourth years.
Conclusion: Transthoracic endoscopic sympathectomy is a safe and effective
method for treating craniofacial hyperhidrosis.